SMITH, MILLER & PATCH, INC. – Trademark Portfolio

Entity Type: 03

SMITH, MILLER & PATCH, INC. holds 22 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 21 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include LIPO-FLAVONOID. The owner is based in NEW YORK, NY.

902 BROADWAY

NEW YORK, NY

22 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

SMITH, MILLER & PATCH, INC.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (21 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does SMITH, MILLER & PATCH, INC. have?

SMITH, MILLER & PATCH, INC. has 22 U.S. trademarks filed with the USPTO. Of these, 1 registered, 21 cancelled.

What trademark classes does SMITH, MILLER & PATCH, INC. file in?

SMITH, MILLER & PATCH, INC. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are SMITH, MILLER & PATCH, INC.'s most well-known trademarks?

SMITH, MILLER & PATCH, INC.'s registered trademark portfolio includes well-known marks such as LIPO-FLAVONOID. These are among 1 currently registered trademark in the portfolio.

What is SMITH, MILLER & PATCH, INC.'s trademark registration success rate?

SMITH, MILLER & PATCH, INC. has a 5% trademark registration rate, with 1 out of 22 resolved applications resulting in successful registration. Currently, 0 applications are pending review.